Deguang Zhi

Title: Deguang Zhi: Innovator in Pharmaceutical Research

Introduction

Deguang Zhi is a notable inventor based in Tianjin, China. He has made significant contributions to the field of pharmaceutical research, particularly in the development of compounds that can aid in the treatment of cardiovascular diseases. His work is characterized by a focus on innovative solutions that address critical health issues.

Latest Patents

Deguang Zhi holds a patent for a compound titled "Thienopyridine ester derivative containing cyano group, preparation method, use and composition thereof." This invention discloses a compound with a specific structure, where R is a cyano group. The compound exhibits antiplatelet aggregation activity and is intended for use in preparing medications that prevent or treat cardiac and cerebral vascular diseases, such as coronary artery syndromes, myocardial infarction, and myocardial ischemia caused by platelet aggregation. He has 1 patent to his name.

Career Highlights

Deguang Zhi is affiliated with the Tianjin Institute of Pharmaceutical Research, where he continues to engage in groundbreaking research. His work has implications for improving patient outcomes in cardiovascular health, showcasing his commitment to advancing medical science.

Collaborations

Some of his notable coworkers include Furong Chen and Chubing Tan, who contribute to the collaborative environment at the Tianjin Institute of Pharmaceutical Research.

Conclusion

Deguang Zhi's innovative work in pharmaceutical research highlights his dedication to developing effective treatments for serious health conditions. His contributions are vital in the ongoing efforts to enhance medical therapies and improve patient care.